Back to search

Article

BCL6 in T cells promotes type 1 diabetes by redirecting fates of insulin-autoreactive B lymphocytes

2025-08-28

Abstract excerpt

Currently approved type 1 diabetes (T1D) immunotherapies broadly target T cells and delay but do not fully prevent diabetes development, highlighting the need for more selective targets. Anti-insulin germinal center B cells are uniquely able to present pathogenic insulin epitopes and drive anti-insulin T cells to adopt a T follicular helper fate. T cell expression of BCL6, a key transcriptional repressor in the ge...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
cbc762a7-b4fa-5065-8d0f-d3c032e6c0ac
DOI
10.1101/2025.08.25.671997
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
BCL6 in T cells promotes type 1 diabetes by redirecting fates of insulin-autoreactive B lymphocytesDOI 10.1101/2025.08.25.671997
Select a neighboring publication to make it the new centre.